Skip to content

Is Flexeril Still Used? The Current Status of Cyclobenzaprine

4 min read

The brand name Flexeril was officially discontinued in the United States around 2023, but its active ingredient, cyclobenzaprine, is still a commonly used prescription medication. As a central nervous system depressant, cyclobenzaprine remains an important tool for the short-term relief of muscle spasms associated with acute musculoskeletal conditions.

Quick Summary

The brand-name Flexeril is no longer manufactured, but its generic form, cyclobenzobenzine, is still widely used to treat muscle spasms. This muscle relaxant is available in generic immediate-release and extended-release capsules.

Key Points

  • Flexeril Discontinued: The brand name Flexeril was retired in 2023, but the medication cyclobenzaprine is not.

  • Generic Cyclobenzaprine Remains: The active ingredient is widely available and prescribed in generic form for muscle spasms.

  • Available in ER Form: The extended-release capsule version of cyclobenzaprine is still available under the brand name Amrix.

  • Short-Term Use Recommended: Cyclobenzaprine is most effective for short-term treatment of muscle spasms, typically for 2-3 weeks.

  • Side Effects Include Sedation: Drowsiness and dry mouth are common side effects, with the level of sedation potentially influencing treatment choice.

  • Important Drug Interactions: Combining cyclobenzaprine with alcohol or other CNS depressants can increase the risk of serious side effects.

  • Generic Equivalent, Same Efficacy: Generic cyclobenzaprine works identically to the original brand name product for treating muscle pain.

In This Article

The End of a Brand: Why Flexeril Was Discontinued

For decades, Flexeril was a prominent and well-known brand name for the muscle relaxant cyclobenzaprine. However, in 2023, the manufacturer ceased production of the brand-name product. It's crucial for patients to understand that this discontinuation was driven by economic factors and generic competition, not by any newly discovered safety issues with the active ingredient itself.

When the patent for the brand-name drug expired, generic versions of cyclobenzaprine became available at significantly lower costs. With generic alternatives offering the exact same active ingredient and therapeutic effect, the brand-name product became less profitable to manufacture and market. The market simply shifted, leading to the phase-out of the Flexeril name. Patients who once took Flexeril are now prescribed generic cyclobenzaprine tablets or the brand-name extended-release version, Amrix.

How Generic Cyclobenzaprine Is Used Today

Generic cyclobenzaprine is a prescription-only muscle relaxant indicated for short-term use, typically for two to three weeks, in conjunction with rest and physical therapy. It helps to relieve muscle spasms, pain, and discomfort caused by conditions like sprains and strains. The medication works by acting on the central nervous system to help relax muscles.

Available Formulations

Cyclobenzaprine is available in two main forms, each with a different dosing schedule:

  • Immediate-Release (IR) Tablets: These are typically taken up to three times per day. Healthcare professionals determine the appropriate strength based on individual patient needs.
  • Extended-Release (ER) Capsules (Amrix): This formulation is taken once daily, offering a more convenient dosing regimen. Healthcare providers will prescribe the suitable strength for the patient.

For older adults (over 65), caution is advised due to increased risk of side effects like confusion and sedation. The extended-release capsules are generally not recommended for this demographic, and a lower dose of the immediate-release tablet may be necessary as determined by a healthcare professional.

Cyclobenzaprine vs. Other Common Muscle Relaxants

When treating muscle spasms, healthcare providers have a variety of options. Choosing the right medication depends on a patient's specific condition, potential for side effects, and other medications they may be taking. Here is a comparison of generic cyclobenzaprine with two other commonly prescribed muscle relaxants.

Feature Cyclobenzaprine (Generic Flexeril) Tizanidine (Generic Zanaflex) Methocarbamol (Generic Robaxin)
Mechanism Centrally-acting muscle relaxant, acts on the brainstem. Chemically related to tricyclic antidepressants. Centrally-acting alpha-2 adrenergic agonist, works in the spinal cord. Centrally-acting muscle relaxant, exact mechanism unknown.
Primary Use Short-term relief of acute, painful musculoskeletal spasms (up to 3 weeks). Manages muscle spasticity from conditions like multiple sclerosis and stroke. Also used off-label for muscle pain. Relief of discomfort from painful musculoskeletal spasms.
Dosage Frequency IR tablets 1-3 times daily; ER capsule once daily. Up to 3-4 times daily. Up to 4 times daily.
Sedation Generally considered more sedating, which can be beneficial for pain-related sleep issues. Can cause significant sedation and dry mouth. Often considered less sedating than cyclobenzaprine.
Drug Interactions Significant interactions with MAOIs, other CNS depressants (including alcohol), and serotonergic drugs. Significant interactions with certain blood pressure medications and CYP1A2 inhibitors. Interactions with other CNS depressants and alcohol.

Important Safety Considerations

While effective, cyclobenzaprine is not without risks. Patients should be aware of potential side effects and interactions to ensure safe usage. Because it is structurally similar to tricyclic antidepressants, it carries some of the same risks and contraindications.

Common side effects include:

  • Drowsiness and fatigue
  • Dry mouth
  • Dizziness
  • Nausea and constipation
  • Headaches

More serious, but less common, side effects can include heart rhythm problems, liver issues, and central nervous system changes like confusion or hallucinations. Patients should seek immediate medical attention if they experience symptoms of serotonin syndrome, which can occur when cyclobenzaprine is combined with other serotonergic agents.

Cyclobenzaprine can intensify the sedative effects of other CNS depressants, making it dangerous to mix with alcohol, opioids, or benzodiazepines. Patients should also avoid cyclobenzaprine within 14 days of taking a monoamine oxidase inhibitor (MAOI).

Conclusion: The Continued Relevance of Cyclobenzaprine

The brand name Flexeril may have been retired, but the medication itself is still very much in use. Its generic counterpart, cyclobenzaprine, continues to be a standard treatment for acute muscle spasms, offering both immediate-release and once-daily extended-release options. Patients should be aware of the shift from the brand name to the generic, follow their doctor's prescription for short-term use, and understand the potential side effects and interactions. By adhering to safe practices, patients can continue to benefit from this effective muscle relaxant for the relief of musculoskeletal pain. Learn more about cyclobenzaprine.

The Legacy of Flexeril

Flexeril Discontinued: The brand name Flexeril was retired in 2023, but the medication cyclobenzaprine is not. Generic Cyclobenzaprine Remains: The active ingredient is widely available and prescribed in generic form. Amrix is Extended-Release: The extended-release capsule formulation of cyclobenzaprine is still available under the brand name Amrix. Short-Term Use Only: Both generic and brand cyclobenzaprine are meant for short-term treatment of muscle spasms, typically for 2-3 weeks. Considered Effective: Cyclobenzaprine is considered an effective muscle relaxant, especially for addressing spasms caused by injuries. Multiple Alternatives Exist: Healthcare providers may choose from various muscle relaxants depending on patient needs, side effects, and dosing preferences. Sedation is a Common Side Effect: Drowsiness is a frequently reported side effect and should be considered, especially for those with insomnia related to muscle spasms. Potential Drug Interactions: Cyclobenzaprine can have dangerous interactions with alcohol, CNS depressants, and certain antidepressants.

Frequently Asked Questions

No, the brand-name drug Flexeril was discontinued and is no longer available in pharmacies. However, its generic version, cyclobenzaprine, is readily available and widely prescribed.

There is no difference in the active ingredient or its function. Flexeril was the brand name for the drug cyclobenzaprine. When the brand name was discontinued, the generic version continued to be sold under the name cyclobenzaprine.

The discontinuation was largely due to economic reasons, including competition from inexpensive and equally effective generic versions of cyclobenzaprine after the patent expired. It was not due to any new safety concerns.

Amrix is an extended-release capsule formulation of cyclobenzaprine. Unlike the immediate-release generic tablets, it is taken once daily. It is still available as a brand-name product.

Cyclobenzaprine is intended for short-term treatment of muscle spasms, typically for no more than two to three weeks. Its effectiveness for long-term use has not been established.

Cyclobenzaprine is not classified as a controlled substance by the DEA and is not physically addictive like an opioid or benzodiazepine. However, misuse can lead to psychological dependence.

Common side effects include drowsiness, dry mouth, dizziness, fatigue, and headaches. These effects are often most pronounced with the immediate-release version of the medication.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.